Neus Virgili Bernado
Corporate Officer/Principal chez ORYZON GENOMICS S.A.
Profil
Neus Virgili Bernado is currently the Chief Intellectual Property Officer at Oryzon Genomics SA since 2011.
Prior to this, Neus worked as the Chief Patent Officer & Head-Legal Affairs at Palau Pharma SA. Neus completed an undergraduate degree from the University of Barcelona in 1990.
Postes actifs de Neus Virgili Bernado
| Sociétés | Poste | Début |
|---|---|---|
| ORYZON GENOMICS S.A. | Corporate Officer/Principal | 01/09/2011 |
Anciens postes connus de Neus Virgili Bernado
| Sociétés | Poste | Fin |
|---|---|---|
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Conseiller Juridique Général | - |
Formation de Neus Virgili Bernado
| University of Barcelona | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORYZON GENOMICS S.A. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Health Technology |
